SCHEMBL6569494

SCHEMBL6569494

C=C[C@]1(O)CC[C@H]2[C@@H]3CCc4cccc(O[Si](C)(C)C(C)(C)C)c4[C@H]3CC[C@@]21C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.40
NR3C1 P04150 4/20 0.40
ESR2 Q92731 4/20 0.39
NR3C2 P08235 1/20 0.39
STS P08842 6/20 0.38
CYP3A4 P08684 3/20 0.36
PGR P06401 2/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
ABCB11 O95342 2/20 0.36
SLC22A2 O15244 1/20 0.36
NR1I2 O75469 1/20 0.36
SHBG P04278 1/20 0.36
HTR1A P08908 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
AR P10275 1/20 0.36
ADRB3 P13945 1/20 0.36
CYP2B6 P20813 1/20 0.36
TBXA2R P21731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1657345 0.82 ESR1 (0.53) ESR1NR3C1ESR2NR3C2STS
SCHEMBL7132037 0.77 STS (0.49) ESR1ESR2STSCYP3A4PGR
SCHEMBL5155997 0.76 SRD5A2 (0.39) ESR1NR3C1ESR2STSCYP3A4
SCHEMBL7060055 0.75 STS (0.34) ESR1ESR2STSCYP3A4PGR
SCHEMBL1657344 0.73 STS (0.39) ESR1NR3C1ESR2NR3C2STS
SCHEMBL1656550 0.71 STS (0.73) ESR1NR3C1ESR2NR3C2STS
SCHEMBL7166132 0.71 STS (0.73) ESR1NR3C1ESR2NR3C2STS
SCHEMBL4572560 0.71 STS (0.73) ESR1NR3C1ESR2NR3C2STS
SCHEMBL8638232 0.69 STS (0.51) ESR1NR3C1ESR2NR3C2STS
SCHEMBL16536413 0.68 ACHE (0.36) HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1405860-A1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use SRI INTERNATIONAL (US) 2004-04-07 EP disclosed